{"id":"https://genegraph.clinicalgenome.org/r/8a0d8125-113b-47c0-92a1-507cfa8c6bfav1.1","type":"EvidenceStrengthAssertion","dc:description":"MSX2 was first associated with autosomal dominant craniosynostosis by Warman et al. in 1993 (PMID: 8357019). The large family originally described was studied in Boston thus their phenotype has since been referred to as \"craniosynostosis, Boston type\" or \"craniosynostosis, Warman type\" (PMID: 23949913, 23918290). At least 3 unique missense variants have been identified in patients with craniosynostosis (PMIDs: 8357019, 23918290, 23949913, 27884935, 28808027). Notably, all variants are at the Pro148 codon in exon 2. Evidence supporting this gene-disease relationship includes case-level, segregation, and experimental evidence. Two mouse models have been generated, thus reaching the maximum score of 4 pts has been reached for animal models (PMIDs: 9917362, 7597092). In summary, MSX2 is definitively associated with autosomal dominant craniosynostosis. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. ","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/8a0d8125-113b-47c0-92a1-507cfa8c6bfa","GCISnapshot":"https://genegraph.clinicalgenome.org/r/ac8a9313-9ef2-4556-9a25-db7fa2ed99ed","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/ac8a9313-9ef2-4556-9a25-db7fa2ed99ed_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10059","date":"2021-01-08T18:48:16.960Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/ac8a9313-9ef2-4556-9a25-db7fa2ed99ed_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10059","date":"2020-09-28T17:00:00.000Z","role":"Approver"}],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ac8a9313-9ef2-4556-9a25-db7fa2ed99ed_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ac8a9313-9ef2-4556-9a25-db7fa2ed99ed_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f85cebe6-ed66-4b69-a281-11ed66168ef6","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/42c80405-8375-475b-bfd1-6c3dd2734903","type":"Finding","dc:description":"membranous bone of the calvaria and in adjacent mesenchymal cells. Whole-mount in situ hybridization performed on neonatal mouse heads revealed Msx2 hybridization signal along a line parallel to the edge of the calvarial bones in the region of the sutures.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8106171","rdfs:label":"MSX2 Expression in Calvarial Bones","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/040fbe6b-d690-4555-b8c1-100d2d1a5adb","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e68aab14-f674-4a26-afc1-ef4dc5a0b79a","type":"Finding","dc:description":"In situ hybridization showed that Msx2 is expressed in the cranial skeletogenic mesenchyme and in the growing calvarial bones.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15198690","rdfs:label":"Expression study MSX2 ALX4","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/fcebd1f7-6111-4023-ac39-4b6fe5c0939e","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/93778af3-957b-48d6-b788-51f32f8aef3a","type":"Finding","dc:description":"Miz1 interacts directly with Msx2 in vitro and enhances the DNA binding affinity of Msx2 for a functionally important element in the rat osteocalcin promoter.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9256341","rdfs:label":"Mizl interaction with Msx2","demonstrates":{"id":"obo:MI_0915"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/ac8a9313-9ef2-4556-9a25-db7fa2ed99ed_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b2df5b81-9fa6-44a3-b3e7-b4e522070b88","type":"EvidenceLine","dc:description":"Although variant specific, this experiment speaks to the mechanism of disease","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/db82cc02-e69e-4fd3-862b-c118a09f1aaf","type":"FunctionalAlteration","dc:description":"The P148H mutation enhanced the Msx2-Mizl interaction by approximately 2-fold. \nThe variantâ€™s augmentation of the Miz1 effect on Msx2 DNA binding suggests this mutation behaves in vivo as a dominant positive and provides a potential explanation of the craniosynostosis phenotype.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9256341","rdfs:label":"P148H augmentation of Msx2-Miz1 binding"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/ac8a9313-9ef2-4556-9a25-db7fa2ed99ed_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3bc02d6d-e523-4010-8688-b58dacff42e7","type":"EvidenceLine","dc:description":"The phenotype is not well recapitulated however it does represent skull involvement.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8c31486c-1b60-44e8-9a7a-306b3adcdf6f","type":"Finding","dc:description":"Phenotypes observed in mice show a correlation between MSX2 and skull formation.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15198690","rdfs:label":"Alx4 and Msx2 in skull development","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/2feb962b-46b9-4932-addb-f306cf9722f4","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/84cf52f7-9d39-49e6-b970-d732c38fa93f","type":"Finding","dc:description":"The phenotypes are overlapping","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9917362","rdfs:label":"Msx2 Gene Dosage in Developing Murine Skull","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/41229adf-ddd6-4ca7-acfd-783e0c1e4494","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c5d12a78-b5f0-4201-a244-38d858309b6b","type":"Finding","dc:description":"The mouse phenotype recapitulates that seen in humans","dc:source":"https://pubmed.ncbi.nlm.nih.gov/7597092","rdfs:label":"Analysis of Cranial Phenotypes in Msx2 Transgenic Mice","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":4}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":6},{"id":"https://genegraph.clinicalgenome.org/r/ac8a9313-9ef2-4556-9a25-db7fa2ed99ed_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ac8a9313-9ef2-4556-9a25-db7fa2ed99ed_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5b8ab4a7-309c-4a61-846a-c92ebe32329a_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23918290","rdfs:label":"Family 1","estimatedLodScore":1.2,"family":{"id":"https://genegraph.clinicalgenome.org/r/5b8ab4a7-309c-4a61-846a-c92ebe32329a","type":"Family","rdfs:label":"Family 1","member":{"id":"https://genegraph.clinicalgenome.org/r/7570a385-3e5e-43f5-b048-6111f9d9fab8","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23918290","rdfs:label":"IV-3","ageType":"AgeAtOnset","ageUnit":"Days","detectionMethod":"Candidate sequencing of MSX2, FGFR2, FGFR3 and TWIST.","firstTestingMethod":"Genotyping","phenotypes":["obo:HP_0030084","obo:HP_0002056","obo:HP_0005274","obo:HP_0030799","obo:HP_0004442","obo:HP_0000520","obo:HP_0000243","obo:HP_0011330"],"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/6e776b04-c277-42a6-9a61-e82ac31d26ae_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23918290","allele":{"id":"https://genegraph.clinicalgenome.org/r/b77fa31f-b261-44e0-afb8-3549dca10d31","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_002449.5(MSX2):c.443C>A (p.Pro148His)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA341436"}}}}},"phenotypePositiveAllelePositive":4,"phenotypes":["obo:HP_0002056","obo:HP_0005274","obo:HP_0030799","obo:HP_0000520","obo:HP_0030084","obo:HP_0004442","obo:HP_0011330","obo:HP_0000243"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/7570a385-3e5e-43f5-b048-6111f9d9fab8"}},{"id":"https://genegraph.clinicalgenome.org/r/c1cc93c2-7892-4b2d-aa26-125ea6da5e3d_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8357019","rdfs:label":"Family 1","family":{"id":"https://genegraph.clinicalgenome.org/r/c1cc93c2-7892-4b2d-aa26-125ea6da5e3d","type":"Family","rdfs:label":"Family 1","member":{"id":"https://genegraph.clinicalgenome.org/r/8d9ab7bc-90f1-4b1e-b762-ddda12343aa4","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8357019","rdfs:label":"I-1","ageType":"AgeAtReport","ageUnit":"Years","ageValue":72,"firstTestingMethod":"Linkage analysis","phenotypeFreeText":"fronto-orbital recession","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/68607fed-1742-4931-bdde-6115c2c6cf3a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8357019","allele":{"id":"https://genegraph.clinicalgenome.org/r/b77fa31f-b261-44e0-afb8-3549dca10d31"}}}},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":13,"proband":{"id":"https://genegraph.clinicalgenome.org/r/8d9ab7bc-90f1-4b1e-b762-ddda12343aa4"},"publishedLodScore":4.8,"sequencingMethod":{"id":"cg:AllGenesSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/030e6399-0cf0-4d9e-ab3c-b86b27586c30_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23949913","rdfs:label":"Bosnian Family","estimatedLodScore":1.81,"family":{"id":"https://genegraph.clinicalgenome.org/r/030e6399-0cf0-4d9e-ab3c-b86b27586c30","type":"Family","rdfs:label":"Bosnian Family","member":{"id":"https://genegraph.clinicalgenome.org/r/05b3de3c-c3fa-4299-bc05-ba0abda51ab3","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23949913","rdfs:label":"III-1","ageType":"AgeAtReport","ageUnit":"Years","ageValue":6,"detectionMethod":"Genome sequencing followed by linkage analysis","firstTestingMethod":"Genotyping","phenotypes":["obo:HP_0002645","obo:HP_0011330","obo:HP_0000601","obo:HP_0002648","obo:HP_0009381","obo:HP_0004440","obo:HP_0000494","obo:HP_0000341","obo:HP_0000262"],"secondTestingMethod":"Linkage analysis","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/c4bfe88e-e9be-4e22-a3ff-17034d735227_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23949913","allele":{"id":"https://genegraph.clinicalgenome.org/r/2b6a1ff9-af0f-43bb-8183-3dac2fa94ad6","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_002449.5(MSX2):c.443C>T (p.Pro148Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA251352"}}}}},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":7,"proband":{"id":"https://genegraph.clinicalgenome.org/r/05b3de3c-c3fa-4299-bc05-ba0abda51ab3"},"sequencingMethod":{"id":"cg:AllGenesSequencing"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":3},{"id":"https://genegraph.clinicalgenome.org/r/ac8a9313-9ef2-4556-9a25-db7fa2ed99ed_ad_other_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/55516b70-389c-47be-89e1-aa54c858a2e0_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0c888a23-5439-4e28-97df-192515bcc9c3","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28808027","rdfs:label":"Patient 1","detectionMethod":"WES","firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0004442","obo:HP_0004440"],"sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/55516b70-389c-47be-89e1-aa54c858a2e0_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28808027","allele":{"id":"https://genegraph.clinicalgenome.org/r/82899182-7add-41e1-b45a-442e5d3358ec","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_002449.5(MSX2):c.442C>T (p.Pro148Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA362229886"}}}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/c4bfe88e-e9be-4e22-a3ff-17034d735227_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Variant pathogenicity supported by functional evidence","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/05b3de3c-c3fa-4299-bc05-ba0abda51ab3"}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/6e776b04-c277-42a6-9a61-e82ac31d26ae_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Variant pathogenicity supported by functional evidence","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7570a385-3e5e-43f5-b048-6111f9d9fab8"}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/68607fed-1742-4931-bdde-6115c2c6cf3a_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Supported by functional evidence. Variant also segregated with disease in another, unrelated large family.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8d9ab7bc-90f1-4b1e-b762-ddda12343aa4"}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/9e4f6c19-c72c-4da4-81e9-397168ae4c9c_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Variant seen in multiple patients affected with Craniosynostosis and absent from gnomAD","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/18a7c0d5-73b8-41ce-a2a0-2937fbc029f6","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27884935","rdfs:label":"Patient 6306","ageType":"AgeAtReport","ageUnit":"Years","ageValue":7,"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0004209","obo:HP_0011304","obo:HP_0000486","obo:HP_0000034","obo:HP_0009778","obo:HP_0001249","obo:HP_0100874","obo:HP_0001363"],"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/9e4f6c19-c72c-4da4-81e9-397168ae4c9c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27884935","allele":{"id":"https://genegraph.clinicalgenome.org/r/b77fa31f-b261-44e0-afb8-3549dca10d31"}}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallAutosomalDominantOtherVariantEvidenceCriteria","strengthScore":2.5}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":5.5}],"evidenceStrength":"Definitive","sequence":1759,"specifiedBy":"GeneValidityCriteria7","strengthScore":11.5,"subject":{"id":"https://genegraph.clinicalgenome.org/r/6cflJ1GHXXY","type":"GeneValidityProposition","disease":"obo:MONDO_0011481","gene":"hgnc:7392","modeOfInheritance":"obo:HP_0000006"},"version":"1.1","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_ac8a9313-9ef2-4556-9a25-db7fa2ed99ed-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}